media

Markets

Market Nav

News Details

14/02/2024 11:54

Transgene Biotek - Board Meeting Outcome for Outcome Of Board Meeting

1) The Board has considered and approved the unaudited Consolidated & Stand-alone Financial Results of the company, for the Quarter ended 31.12.2023 in accordance with the Indian Accounting Standards (IND-AS) as per Companies (Indian Accounting Standards) Rules, 2015.\r\n\r\n2) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company, for the quarter ended 31.12.2023 has also been approved.\r\n\r\n